Skip to main content
Fig. 2 | BMC Endocrine Disorders

Fig. 2

From: Autoimmune polyglandular syndrome type 2 and autoimmune hepatitis with thymoma-associated myasthenia gravis: case report

Fig. 2

Clinical course after diagnosis of APS-2. Five months after this diagnosis, she was diagnosed with thymoma-associated MG. Anti-AchR-Ab titer gradually decreased. * Immuno-suppressants: Under treatment with azathioprine (50 mg/day), total thymectomy was conducted. After thymectomy, tacrolimus (3 mg/day) was started instead of azathioprine, and 25 months later, it was changed to cyclosporine (50 mg/day). Ten months later, the treatment was changed to ambenonium (5 mg/day), and ceased after 10 months (at 52 months)

Back to article page